DEXMETHYLPHENIDATE HYDROCHLORIDE | A077107 | TEVA PHARMACEUTICALS USA
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition Amendment from Senores Pharmaceuticals, Inc. FDA-2026-P-7183 · 8 docket documents Senores Pharmaceuticals, Inc. filed an amendment to a citizen petition requesting that FDA establish conditions of suitability under Section 505(i) for a generic drug product. The petition seeks regulatory guidance on manufacturing and formulation requirements necessary to support approval of an abb | Suitability | 2026-07-21 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.